Meta facebook tracking pixel

Listen Now

Topics Covered

  • Overview of Bladder Cancer, Including Staging & Grading
  • Standard of Care
  • New Treatment Approaches
  • Update on Clinical Trials: How Research Increases Your Treatment Options
  • The Role of Diagnostic Technologies, Genomics & Precision Medicine
  • Targeted Treatments: Predicting Response to Treatment
  • The Role of Immunotherapy
  • Communicating with Your Health Care Team about Quality-of-Life Concerns
  • Follow-Up Care Appointments & Plans
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
  • Nutrition & Hydration Concerns & Tips
  • Questions for Our Panel of Experts

Our Panel of Experts

Presenter

Arnab Basu, MD, MPH, FACP

Medical Oncologist, Genitourinary Oncology, Senior Associate Consultant, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida

Presenter

Karine Tawagi, MD

Assistant Professor of Medicine, Division of Hematology/Oncology, Genitourinary Oncology, University of Illinois in Chicago

Presenter

Stephanie A. Berg, DO

Instructor of Medicine, Harvard Medical School, Genitourinary Oncologist, Lank Center, Dana-Farber Cancer Institute

Presenter

Diana L. Bearden, MS, RD, CSO, LD, CNSC

Oncology Dietitian, Michael E. DeBakey VA Medical Center

Presenter

Patricia Rios, MBA, MPH

Director, Education & Advocacy, Bladder Cancer Advocacy Network

Presenter

Sarah Tennenhaus, MSW, OSW-C

Oncology Social Worker, Support Group Program Manager, CancerCare

Brochure

You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on May 20, 2026.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top